We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

By LabMedica International staff writers
Posted on 10 Mar 2025
Print article
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true for infants born as early as six to seven months of pregnancy, known as extremely preterm infants. These infants essentially continue their development outside the womb, facing even greater risks. Research in this population is complicated because conventional tests, such as blood draws, can be life-threatening due to the limited blood supply in these tiny patients. Now, a new methodology, combined with advanced techniques that analyze multiple molecular markers, is enabling researchers to gain valuable insights into the immune systems of extremely preterm infants more safely.

Researchers believe that early exposures to infections and environmental factors play a crucial role in shaping immune function later in life, though the exact impact of premature birth on the immune system is still under investigation. It was once thought that infant immune systems were not fully mature at birth, but accumulating evidence suggests that full-term babies are born with functioning immune systems, albeit different from those of adults. For preterm infants, determining whether this is also true has been challenging. Immune system studies typically require blood samples, and standard research methods use between 10 to 50 milliliters of blood. Collecting that amount from preterm infants could be harmful, draining their blood supply. Now, with only two drops of blood, researchers at Yale School of Medicine (YSM, New Haven, CT, USA) have demonstrated that preterm babies possess unique immune systems capable of responding to threats both before and after birth. This research, published in Science Translational Medicine, marks a key step in understanding the immune systems of extremely preterm infants, which is vital for improving care for this vulnerable group.

In their study, YSM researchers combined a protocol developed by Swedish researchers with advanced molecular techniques, enabling them to gather substantial data from just two drops of blood. Collaborating with Yale’s NOURISH team, the researchers collected blood samples from 10 extremely preterm infants, ranging from their first week to two months of age. They then analyzed protein expression and cell types in these samples, comparing them to data from adults and full-term infants. The results showed that preterm infants have a full array of immune cells, similar to those in adults and full-term infants. These babies even had memory T and B cells, which the immune system uses to recognize and respond to previously encountered threats. This finding suggests that these preterm infants were not only reacting to environmental exposures but may have also developed immunity while still in the womb.

However, the development of immune cells in preterm infants differed from that in full-term infants. The researchers observed that protein pathways and cell types related to inflammation were more active in extremely preterm infants, and this inflammation persisted for a longer period than in full-term infants. Around half of the preterm infants in the study had been exposed to an infection in the placenta before birth. These infants showed even higher levels of inflammatory cells in their blood than those who had not been exposed to such an infection. The long-term implications of these findings for the health of preterm infants remain unclear. While large-scale epidemiological studies suggest that early life exposure to pathogens and other immune triggers may increase the risk of conditions like asthma and irritable bowel syndrome, some early exposures also seem to protect against diseases like diabetes.

Though this small cohort has not yet provided enough data to establish definitive links, the researchers hope to shed more light on these potential connections. The team has now expanded their study to include around 250 preterm infants and is recruiting a comparable group of full-term infants for long-term observation, with plans to follow these infants for at least a year. They are also beginning to collect additional samples, including stool, skin, and nasal swabs, to further explore the development of the immune system in early life. The researchers remain optimistic about their findings and reassure parents that even preterm infants have the ability to combat infections and develop immunity despite arriving early into the world.

“The more premature an infant is, the more complications there are,” said Liza Konnikova, MD, PhD, an associate professor of pediatrics, immunobiology, and reproductive sciences at YSM and senior author of the study. “Our goal is to determine how long early-exposure impacts last, and whether they change your risk one way or another.”

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
Ultra-Low Temperature Freezer
iUF118-GX

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.